Define shock,define obstetrics shock,types of shock encountered in obstetrics,stages of shock, challenges of diagnosing shock in obstetrics, shock index and its importance Massive transfusion protocol and its indications Investigations Management

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Searching PubMed

obstetric shock management massive transfusion

Reading File
Reading File
I now have excellent content from multiple authoritative textbooks. Let me compile the comprehensive answer.

Shock in Obstetrics: A Comprehensive Overview


1. Definition of Shock

Shock is the widespread failure of the circulatory system to oxygenate and nourish the body adequately. It represents a state of global tissue hypoperfusion in which oxygen delivery is insufficient to meet cellular metabolic demands. At the cellular level, shock alters mitochondrial energy transfer - without adequate oxygen, cells catabolize fuel to lactate, leading to cellular dysfunction, organ failure, and death.
Critically: shock can occur with a normal blood pressure, and not all hypotensive patients are in shock. The presence of a base deficit more negative than -4 mEq/L or serum lactate >4.0 mmol/L warrants a presumptive diagnosis of shock even with normal vital signs.
  • Rosen's Emergency Medicine, p. 58

2. Definition of Obstetric Shock

Obstetric shock is shock occurring in the context of pregnancy, labour, delivery, or the puerperium (up to 6 weeks postpartum). It is defined as an acute circulatory failure resulting from pregnancy-related causes leading to inadequate tissue perfusion and cellular hypoxia. It is a leading contributor to maternal morbidity and mortality worldwide.
The physiological changes of pregnancy - increased blood volume (40-50%), increased cardiac output, and decreased systemic vascular resistance - profoundly alter the clinical presentation and thresholds for recognition of shock in obstetric patients.

3. Types of Shock Encountered in Obstetrics

A. Haemorrhagic / Hypovolaemic Shock (Most Common)

The dominant type in obstetrics. Caused by rapid reduction in intravascular volume.
Causes:
  • Antepartum: Placenta praevia, placental abruption, uterine rupture, ectopic pregnancy (early pregnancy)
  • Intrapartum: Uterine rupture, cord prolapse with vascular injury
  • Postpartum: Uterine atony (most common cause of PPH, ~70%), retained placenta, genital tract lacerations, placenta accreta spectrum (PAS), uterine inversion, coagulopathy (DIC)
Obstetric haemorrhage has the lowest case fatality rate of all causes of maternal mortality, yet it is the most frequent cause of obstetric shock. The most dangerous settings are haemorrhage complicated by DIC, placental implantation abnormalities, and broad ligament/posterior uterine tears causing concealed internal bleeding.
  • Creasy & Resnik's Maternal-Fetal Medicine, p. 1114

B. Distributive Shock

  • Septic shock: Septic abortion, chorioamnionitis, endometritis, pyelonephritis, necrotising fasciitis. Characterised by vasodilation and reduced SVR (hyperdynamic state initially).
  • Anaphylactic shock: Reaction to antibiotics (oxytocin, penicillin), blood products, latex, anaesthetic agents.
  • Neurogenic shock: High spinal anaesthesia block.

C. Cardiogenic Shock

  • Peripartum cardiomyopathy, severe pre-eclampsia/eclampsia with cardiac failure, amniotic fluid embolism (AFE) with ventricular dysfunction, myocardial infarction during pregnancy.
  • AFE is one of the most feared obstetric emergencies - presents with sudden cardiovascular collapse during labour or delivery, followed by profuse bleeding and DIC.
  • Creasy & Resnik's Maternal-Fetal Medicine, p. 1114

D. Obstructive Shock

  • Pulmonary embolism (especially peripartum), amniotic fluid embolism (mixed obstructive/distributive), cardiac tamponade, tension pneumothorax.

4. Stages of Shock

Shock progresses through recognisable stages (primarily described for haemorrhagic shock):
StageBlood LossPhysiologyClinical Features
Stage I - CompensatedUp to 15% (~750 mL)Baroreceptor activation, increased HR, peripheral vasoconstrictionMild tachycardia, normal BP, normal pulse pressure, normal urine output, anxious
Stage II - Mild Decompensation15-30% (750-1500 mL)Declining ventricular filling, narrowing pulse pressureHR 100-120, diastolic BP rises, pulse pressure narrows, urine output 20-30 mL/hr, mildly anxious
Stage III - Progressive30-40% (1500-2000 mL)Significant fall in cardiac output and BPHR >120, frank hypotension, SBP <90 mmHg, pale/cold/clammy skin, urine output 5-15 mL/hr, confusion
Stage IV - Irreversible>40% (>2000 mL)Circulatory collapse, end-organ failureHR >140, SBP unrecordable, no urine output, unconscious, moribund
Key cellular/biochemical markers of progression:
  • Rising lactate (>4 mmol/L = severe)
  • Worsening base deficit (more negative than -4 mEq/L)
  • A combination of worsening base deficit + increasing lactate + falling urine output = persistent/worsening shock
  • Rosen's Emergency Medicine, p. 58-59

5. Challenges of Diagnosing Shock in Obstetrics

Obstetric patients are uniquely difficult to assess for shock due to profound physiological adaptations of pregnancy:
  1. Expanded blood volume: Plasma volume increases by 40-50% and total blood volume by 30-35%. This means a pregnant woman can lose >1000 mL before showing classical signs of hypovolaemia. The textbook signs appear late.
  2. Physiological tachycardia and hypotension of pregnancy: Resting HR is already elevated in pregnancy (by ~15-20 bpm) and BP falls in the second trimester, making it difficult to identify pathological changes.
  3. Masked hypotension: Peripheral vasoconstriction in haemorrhagic shock can maintain a near-normal BP even with 25-30% blood loss. Diastolic BP may even rise initially as pulse pressure narrows.
  4. Variable HR response: As Rosen's notes, "the responses of HR and BP are notoriously variable in haemorrhage; no firm conclusion can be made at the bedside about the presence, absence, or degree of haemorrhagic shock by simple evaluation of HR and BP."
  5. Concealed haemorrhage: Placental abruption, broad ligament haematoma, posterior uterine rupture - blood loss may be entirely internal with no visible bleeding.
  6. Coexisting conditions: Pre-eclampsia causes relative hypertension, so a woman who is "normotensive" may actually be severely hypovolaemic relative to her baseline. Chronic hypertension similarly masks the degree of shock.
  7. Fetal distress as early indicator: Uteroplacental blood flow is compromised early (non-essential circulation), so fetal heart rate abnormalities can precede maternal haemodynamic compromise.
  8. Rapid deterioration: The physiological reserve allows compensation until a sudden decompensation occurs, often with rapid, catastrophic decline.
  9. Coagulopathy development: Obstetric haemorrhage is particularly prone to early development of DIC (especially abruption, AFE, sepsis, prolonged hypotension), compounding the haemorrhage.

6. Shock Index and Its Importance in Obstetrics

Definition

Shock Index (SI) = Heart Rate / Systolic Blood Pressure
A normal SI is 0.5 to 0.7 in healthy non-pregnant adults.

Obstetric Shock Index (O-SI)

In obstetric practice, a modified threshold applies. The Obstetric Shock Index (O-SI) uses the same formula but with adjusted thresholds:
  • Normal in pregnancy: approximately 0.7-0.9 (slightly higher than non-pregnant due to physiological tachycardia and lower BP)
  • Concerning: SI ≥ 0.9
  • Significant haemodynamic compromise: SI ≥ 1.0
  • Severe obstetric shock: SI ≥ 1.7

Importance

  • Early detection: The SI rises before conventional vital sign thresholds are crossed, making it useful for identifying haemorrhage and impending shock before overt hypotension develops.
  • Compensates for pregnancy physiology: Because SI incorporates both HR and SBP, it captures the narrowing pulse pressure and rising HR that characterise early compensated shock even when individual values appear normal.
  • Predicts transfusion need: An elevated SI (≥1.0) at triage has been associated with need for blood transfusion and ICU admission.
  • Simple bedside tool: Requires no equipment beyond a pulse and BP reading; can be calculated immediately.
  • Serial monitoring: Trends in SI are as important as a single value. A rising SI indicates deterioration; a falling SI with resuscitation indicates improvement.
  • Limitations: Can be falsely reassuring in women with pre-eclampsia/chronic hypertension (elevated BP masks true haemodynamic compromise); beta-blocker use blunts the tachycardia response.

7. Massive Transfusion Protocol (MTP)

Definition

Massive transfusion is classically defined as transfusion of >10 units of packed red blood cells (PRBCs) within 24 hours. A more operationally useful definition is ≥3 units of PRBCs in 1 hour, or use of 4 or more blood components in 30 minutes.
The MTP is a pre-established, systematic institutional protocol that coordinates the rapid delivery of blood products in fixed ratios to manage life-threatening haemorrhage.
  • Rosen's Emergency Medicine, p. 2430

Indications for MTP Activation in Obstetrics

  • Estimated blood loss >1500 mL with ongoing haemorrhage
  • Clinical shock not responding to initial resuscitation (≥2 units PRBCs in 20 min with ongoing bleeding)
  • Shock Index ≥ 1.0 to 1.7 with active haemorrhage
  • Anticipated massive haemorrhage (placenta accreta spectrum, placenta praevia in labour, uterine rupture)
  • Any obstetric haemorrhage with developing coagulopathy (DIC, INR >1.5, fibrinogen <2 g/L)
  • Haemorrhage with haemodynamic instability despite uterotonics and initial measures
Every obstetric unit needs a massive transfusion protocol, and women with suspected morbidly adherent placenta (accreta, increta, percreta) should always deliver in a centre capable of MTP and rapid caesarean hysterectomy.
  • Creasy & Resnik's Maternal-Fetal Medicine, p. 1113

Blood Product Ratios

Current evidence supports a 1:1:1 ratio of PRBCs : FFP : Platelets - approximating reconstitution of whole blood. A large multicentre RCT comparing 1:1:1 vs 2:1:1 showed no difference in 30-day mortality, but fewer patients in the 1:1:1 group died of exsanguination at 24 hours.
  • Rosen's Emergency Medicine, p. 2430

Additional MTP Components

  • Tranexamic acid (TXA): 1g IV over 10 minutes, given within 3 hours of onset of PPH - an RCT demonstrated efficacy in reducing maternal death from PPH. Should be integrated into all institutional PPH protocols.
  • Creasy & Resnik's Maternal-Fetal Medicine, p. 1114
  • Cryoprecipitate: For fibrinogen replacement (target fibrinogen >2 g/L, especially in obstetric haemorrhage where hypofibrinogenaemia is an early and specific marker)
  • Calcium: Ionised hypocalcaemia is common with rapid transfusion (citrate chelation); IV calcium chloride or gluconate should be administered
  • Recombinant Factor VIIa: Considered in refractory coagulopathic haemorrhage not responding to standard products

8. Investigations

Immediate / Point-of-Care

InvestigationPurpose
FBC (Full Blood Count)Haemoglobin (note: underestimates acute blood loss due to haemodilution lag), platelet count
Crossmatch / Group & ScreenBlood typing; group O Rh(D)-negative RBCs for emergency use if unknown type (especially women of childbearing potential)
Coagulation screen (PT, APTT, INR)Identify coagulopathy; PT/APTT >1.5x normal indicates need for FFP
FibrinogenEarly marker in obstetric haemorrhage; fibrinogen <2 g/L predicts progression; target >2 g/L
Arterial Blood Gas (ABG)pH, base deficit, lactate - most sensitive early markers of tissue hypoperfusion
Serum lactate>4 mmol/L = significant shock; serial values guide resuscitation
Urine outputFoley catheter: <0.5 mL/kg/hr = severe renal hypoperfusion

Additional Investigations

InvestigationPurpose
Urea, creatinine, electrolytesRenal function, electrolyte disturbances (hypocalcaemia, hyperkalaemia) during MTP
Liver function testsBaseline; HELLP syndrome diagnosis in pre-eclampsia
Thromboelastography (TEG) / ROTEMGoal-directed coagulation assessment; superior to conventional coagulation studies for guiding component therapy; identifies hyperfibrinolysis
D-dimer, fibrin degradation productsDiagnose DIC
Serum electrolytes - Calcium, Magnesium, PotassiumMonitor during massive transfusion (citrate toxicity, hypokalaemia or hyperkalaemia)
Bedside ultrasound (FAST/echo)Identify intra-abdominal haemorrhage, cardiac function, AFE
Transthoracic echocardiographyEarly TTE for ventricular failure assessment in AFE/cardiogenic shock
Chest X-rayPulmonary oedema, pneumothorax
Blood cultures x2If septic shock suspected
Lactate dehydrogenase, blood filmHELLP, TTP, microangiopathic haemolytic anaemia
In hypovolaemia, the CBC will underestimate blood loss - clinical assessment and lactate/base deficit are more reliable early indicators.
  • Henry's Clinical Diagnosis and Management, p. 881

9. Management of Obstetric Shock

A. Immediate Resuscitation (First 15-30 minutes)

Airway and Breathing
  • Airway assessment and protection; high-flow oxygen (15 L/min via non-rebreather mask)
  • Early intubation if airway at risk, SpO2 <90%, or GCS <9
  • Rapid sequence induction if intubation required (full stomach precaution in all obstetric patients)
Circulation / IV Access
  • Two large-bore IV lines (14-16G) in antecubital fossae; intraosseous if IV access fails
  • Consider central venous access early in refractory shock
  • Arterial line for continuous BP monitoring and serial ABG sampling
Positioning
  • Left lateral tilt (15-30°) until delivery to relieve aortocaval compression by the gravid uterus - failure to do so further reduces venous return
Fluid Resuscitation - Damage Control Resuscitation
  • Crystalloids: restricted use; avoid large volumes (dilutional coagulopathy, hypothermia, acidosis)
  • The goal is permissive hypotension in haemorrhagic shock until surgical control (target SBP 80-90 mmHg), EXCEPT in pre-eclampsia/head injury
  • Balanced transfusion (1:1:1 PRBCs:FFP:Platelets) is the cornerstone - replace blood with blood, not crystalloid
Uterotonic agents (for PPH):
  • Oxytocin 10 IU IM (or 40 IU in 500 mL normal saline IV infusion)
  • Ergometrine 0.5 mg IM (avoid in hypertension)
  • Carboprost (15-methyl PGF2α) 0.25 mg IM every 15 min up to 8 doses
  • Misoprostol 800-1000 mcg sublingual/rectal if other uterotonics unavailable

B. Source Control / Definitive Treatment

  • PPH: Uterine massage, bimanual compression, intrauterine balloon tamponade (Bakri balloon), uterine compression sutures (B-Lynch), uterine/internal iliac artery ligation, interventional radiology (uterine artery embolisation), hysterectomy as last resort
  • Ectopic pregnancy: Emergency laparoscopy or laparotomy
  • Uterine rupture: Emergency laparotomy and repair/hysterectomy
  • Placenta accreta spectrum: Planned delivery at tertiary centre; often requires hysterectomy
  • Septic shock: IV antibiotics within 1 hour (broad-spectrum, e.g., piperacillin-tazobactam + metronidazole), source control (evacuation of septic uterus), vasopressors (noradrenaline first-line)
  • AFE: Aggressive cardiopulmonary support (intubation, pressors), MTP with emphasis on coagulation factors, early TTE, consider venoarterial ECMO for refractory ventricular dysfunction
  • Creasy & Resnik's Maternal-Fetal Medicine, p. 1114

C. MTP Management and Monitoring

  • Monitor FBC, coagulation, fibrinogen every 30-60 minutes during active MTP
  • Targets:
    • Hb >8 g/dL (≥7 g/dL acceptable when bleeding controlled)
    • Platelets >50 × 10⁹/L (>75-100 × 10⁹/L in active DIC)
    • PT/APTT <1.5x normal
    • Fibrinogen >2 g/L
    • pH >7.35, Temperature >36°C
    • Ionised Ca²⁺ >1.1 mmol/L

D. Complications of Massive Transfusion to Anticipate and Prevent

  • Hypothermia: Use blood warmers, warming blankets - hypothermia reduces clotting factor activity
  • Hypocalcaemia: Citrate chelation; administer IV calcium routinely
  • Metabolic acidosis/alkalosis: Optimise oxygen delivery and ventilation; sodium bicarbonate not routinely recommended
  • Dilutional coagulopathy: Prevented by 1:1:1 ratio
  • Transfusion-associated circulatory overload (TACO)
  • Transfusion-related acute lung injury (TRALI)
  • Hyperkalaemia/hypokalaemia: Monitor electrolytes serially

E. Monitoring and End-Points of Resuscitation

  • Serial lactate and base deficit (downward trend = adequate resuscitation)
  • Urine output >0.5 mL/kg/hr (normal >1 mL/kg/hr)
  • Improving HR and BP
  • Improving mental status
  • TEG/ROTEM-guided component therapy when available - goal-directed approach reduces overall transfusion requirements

Quick Reference Summary

ParameterNormal (Non-pregnant)Obstetric Concern
HR60-100 bpm>100 bpm
SBP>100 mmHg<90 mmHg = shock
Shock Index0.5-0.7≥0.9 concerning, ≥1.0 significant
Lactate<2 mmol/L>4 mmol/L = shock
Base deficit> -2 mEq/L< -4 mEq/L = shock
Fibrinogen2-4 g/L<2 g/L = critical in obstetrics
Urine output>1 mL/kg/hr<0.5 mL/kg/hr = severe hypoperfusion

Sources: Rosen's Emergency Medicine (9780323757898) | Creasy & Resnik's Maternal-Fetal Medicine (9780323828499) | Henry's Clinical Diagnosis and Management by Laboratory Methods (9780323673204) | Tietz Textbook of Laboratory Medicine (9780323775724)
This is a shared conversation. Sign in to Orris to start your own chat.